about
Combating Tuberculosis Infection: A Forbidding ChallengeCombining cheminformatics methods and pathway analysis to identify molecules with whole-cell activity against Mycobacterium tuberculosisRepositioning: the fast track to new anti-malarial medicines?Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents.Validating new tuberculosis computational models with public whole cell screening aerobic activity datasets.Finding promiscuous old drugs for new uses.Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.Screening of antifungal azole drugs and agrochemicals with an adapted alamarBlue-based assay demonstrates antibacterial activity of croconazole against Mycobacterium ulcerans.A High Throughput Screening Assay for Anti-Mycobacterial Small Molecules Based on Adenylate Kinase Release as a Reporter of Cell Lysis.Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-Drug Resistant Mycobacterium tuberculosis Isolates.A Cassette Containing Thiostrepton, Gentamicin Resistance Genes, and dif sequences Is Effective in Construction of Recombinant Mycobacteria.Tuberculosis drugs: new candidates and how to find more.Drug repositioning in the treatment of malaria and TB.Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv.Antibacterial activity of long-chain fatty alcohols against mycobacteria.Could repurposing existing drugs be an efficient protective method against microbial biologic threats?First total synthesis of Debilisone C.
P2860
Q26750683-E9F6AAFF-37E8-40A0-93B5-BF8426D40361Q28709665-F0E756B6-22B6-4BCD-9767-EBEA3F649AE3Q33612012-4247C894-AAAD-4C2B-851C-A85C672D4ABBQ33868685-1CB0871C-CB79-4465-AAB0-7F36D1F13AF9Q33891020-0CE94706-1AEC-42BA-AC0F-7378C7862A95Q33910025-AA679698-1637-43E2-BF92-A5449D0A2F43Q34255402-F047D227-A77A-446D-B45B-36653810B35EQ34420330-EA37F76C-A9CD-47E0-8F4C-311BABD7635CQ35670579-0841F5E5-6EB6-4CF9-ABDA-A81A9F58481BQ36320782-BD793047-3586-460B-AC36-4EE2C4CD166BQ37719059-72836734-737D-42C3-B6EC-20D473586DEEQ37894691-FA2F1396-B251-42D9-9022-EA5DF8FF2072Q37924298-F015A1CD-636F-4E46-822E-37E6991C9108Q39712350-F72C4C58-642F-4460-899B-AD028894350EQ40475389-73E0BC30-1485-4070-B52B-21483AD2A193Q45905845-BB1088B3-912E-46D0-9BFB-A88F0795C225Q46963578-39538345-9837-4838-BB7B-5ECBD6CB6DFCQ51842842-73B0FB16-3CA3-4C64-AF07-33678B6B0FF7
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
New anti-tuberculosis agents amongst known drugs.
@ast
New anti-tuberculosis agents amongst known drugs.
@en
type
label
New anti-tuberculosis agents amongst known drugs.
@ast
New anti-tuberculosis agents amongst known drugs.
@en
prefLabel
New anti-tuberculosis agents amongst known drugs.
@ast
New anti-tuberculosis agents amongst known drugs.
@en
P2093
P2860
P1433
P1476
New anti-tuberculosis agents amongst known drugs.
@en
P2093
Debra L Taylor
Justin S Bryans
Kathryn E A Lougheed
Roger S Buxton
Simon A Osborne
P2860
P304
P356
10.1016/J.TUBE.2009.07.002
P577
2009-08-20T00:00:00Z